| Dr Margo F Tolins-mejia, MD | |
|
4040 Coon Rapids Blvd Nw, Suite 120, Minneapolis, MN 55433-2522 | |
| (763) 427-9980 | |
| (763) 427-9908 |
| Full Name | Dr Margo F Tolins-mejia |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 4040 Coon Rapids Blvd Nw, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033156450 | NPI | - | NPPES |
| 817780500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 264820 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Margo F Tolins-mejia, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Dr Margo F Tolins-mejia, MD 4040 Coon Rapids Blvd Nw, Suite 120, Minneapolis, MN 55433-2522 Ph: (763) 427-9980 |
News Archive
The fungus Aspergillus fumigatus is capable of rapid genetic adaptation in both natural environments and in humans according to a study published in The Lancet Infectious Diseases by Radboud university medical center/CWZ and Wageningen University & Research.
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Sprycel (dasatinib) for the treatment of adults in all phases of chronic myeloid leukemia (CML) (chronic, accelerated, or myeloid or lymphoid blast phase) with resistance or intolerance to prior therapy including Gleevec (imatinib mesylate).
Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.
Michael Hutz, a second year student at Loyola University Chicago Stritch School of Medicine, has been invited to attend a prestigious Vatican conference on adult stem cell research.
Sorin Group: Revenues of €171.4 million, a 2.1% decline (-4.9% as reported) over the same period last year.
› Verified 7 days ago
Pascal Frino, M.D Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |